• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠侧向发育型肿瘤黏膜下浸润的病理特征及危险因素

Pathological features and risk factors for submucosal infiltration of colorectal lateral spreading tumors.

作者信息

Shi Wen-Jie, Han Jian-Bo, Cheng Gong-Ming, Liu Xu-Cheng, Tao Xue-Wen, Shan Liu-Qun

机构信息

Department of General Surgery, The Second Hospital of Nanjing, Nanjing 210000, Jiangsu Province, China.

出版信息

World J Gastrointest Surg. 2025 Aug 27;17(8):107230. doi: 10.4240/wjgs.v17.i8.107230.

DOI:10.4240/wjgs.v17.i8.107230
PMID:40949389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12427050/
Abstract

BACKGROUND

To observe the endoscopic and pathological characteristics of laterally spreading tumors (LSTs) and explore the risk factors for carcinogenesis and submucosal infiltration.

AIM

To analyze the clinicopathological features of colorectal LSTs treated endoscopically and determine risk factors associated with carcinogenesis and submucosal invasion, providing evidence-based guidance for optimal treatment strategy selection.

METHODS

This study retrospectively analyzed the sex, age, and endoscopic and pathological features of patients who underwent endoscopic treatment for colorectal LSTs in our hospital from January 2021 to July 2024. Single-factor analysis was used to identify the risk factors for cancer and submucosal infiltration, and the factors with statistical significance were included in multivariate logistic regression analysis.

RESULTS

A total of 422 patients, including 224 males and 198 females, aged 63.45 ± 9.23 years, were included. There were 456 LST lesions in total. The length of the endoscopically resected specimens was 3.01 ± 0.48 cm, and the length of the lesions was 2.37 ± 1.59 cm. It was located in 115 rectums (25.2%), 40 sigmoid colon (8.8%), 26 descending colon (5.7%), 109 transverse colon (23.9%), 112 ascending colon (24.6%), and 54 ileocecal regions (11.8%). Endoscopic submucosal dissection (ESD) was performed in 237 patients (52.0%), and endoscopic mucosal resection (EMR) was performed in 95 patients (20.8%). There were 113 EMR with precutting cases (24.8%), 11 ESD with snare cases (2.4%), 4 delayed bleeding cases and 5 intraoperative perforations. The pathological results revealed 119 cases of low-grade intraepithelial neoplasia (26.1%), 221 cases of high-grade intraepithelial neoplasia (48.5%), 82 cases of intramucosal carcinoma (18.0%), and 34 cases of submucous invasive carcinoma (7.5%). Multiple logistic regression analyses revealed that lesion size ( > 2 cm), lesion location (rectal) and endoscopic classification [false depressed tubulovillous adenoma (LST-NG pseudodepressed type, LST-NG-PD), type 1 particles (LST-G homogenous type), and LST-G nodular mixed type], accompanied by large nodules (with) were independent risk factors for carcinogenesis; endoscopic classification (LST-NG-PD) and the presence of large nodules were independent risk factors for submucosal infiltration.

CONCLUSION

These risk factors provide practical guidance for treatment selection: LST-NG-PD with large nodules should prioritize ESD, while high-risk rectal lesions > 2 cm may require additional imaging evaluation before endoscopic resection.

摘要

背景

观察侧向发育型肿瘤(LSTs)的内镜及病理特征,探讨其癌变及黏膜下浸润的危险因素。

目的

分析经内镜治疗的大肠LSTs的临床病理特征,确定与癌变及黏膜下浸润相关的危险因素,为优化治疗策略选择提供循证指导。

方法

本研究回顾性分析了2021年1月至2024年7月在我院接受大肠LSTs内镜治疗患者的性别、年龄、内镜及病理特征。采用单因素分析确定癌症及黏膜下浸润的危险因素,将具有统计学意义的因素纳入多因素logistic回归分析。

结果

共纳入422例患者,其中男性224例,女性198例,年龄63.45±9.23岁。共有456个LST病变。内镜切除标本长度为3.01±0.48cm,病变长度为2.37±1.59cm。病变位于直肠115例(25.2%)、乙状结肠40例(8.8%)、降结肠26例(5.7%)、横结肠109例(23.9%)、升结肠112例(24.6%)、回盲部54例(11.8%)。237例(52.0%)患者行内镜黏膜下剥离术(ESD),95例(20.8%)患者行内镜黏膜切除术(EMR)。有113例EMR预切开病例(24.8%)、11例ESD圈套器病例(2.4%)、4例迟发性出血病例和5例术中穿孔病例。病理结果显示低级别上皮内瘤变119例(26.1%)、高级别上皮内瘤变221例(48.5%)、黏膜内癌82例(18.0%)、黏膜下浸润癌34例(7.5%)。多因素logistic回归分析显示,病变大小(>2cm)、病变部位(直肠)及内镜分类[假凹陷性管状绒毛状腺瘤(LST-NG假凹陷型,LST-NG-PD)、1型颗粒状(LST-G均质型)及LST-G结节混合型],伴有大结节(有)是癌变的独立危险因素;内镜分类(LST-NG-PD)及大结节的存在是黏膜下浸润的独立危险因素。

结论

这些危险因素为治疗选择提供了实践指导:有大结节的LST-NG-PD应优先选择ESD,而>2cm的高危直肠病变在内镜切除前可能需要额外的影像学评估。

相似文献

1
Pathological features and risk factors for submucosal infiltration of colorectal lateral spreading tumors.结直肠侧向发育型肿瘤黏膜下浸润的病理特征及危险因素
World J Gastrointest Surg. 2025 Aug 27;17(8):107230. doi: 10.4240/wjgs.v17.i8.107230.
2
Endoscopic resection of colorectal laterally spreading tumors: Clinicopathologic characteristics and risk factors for treatment outcomes.结直肠侧向发育型肿瘤的内镜切除:临床病理特征及治疗结果的危险因素
World J Gastrointest Endosc. 2025 Jun 16;17(6):106412. doi: 10.4253/wjge.v17.i6.106412.
3
Clinical Pathological Features and Carcinogenic Risk Factors of Colorectal Lateral Spreading Tumors With Skirt Features.具有裙边特征的结直肠侧向发育型肿瘤的临床病理特征及致癌危险因素
Can J Gastroenterol Hepatol. 2025 Jun 11;2025:9920606. doi: 10.1155/cjgh/9920606. eCollection 2025.
4
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.内镜及手术切除 T1a/T1b 食管肿瘤:系统评价。
World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424.
5
Endoscopic mucosal resection and endoscopic submucosal dissection for colorectal lesions: A systematic review.内镜下黏膜切除术和内镜黏膜下剥离术治疗结直肠病变:系统评价。
Crit Rev Oncol Hematol. 2016 Aug;104:138-55. doi: 10.1016/j.critrevonc.2016.06.008. Epub 2016 Jun 16.
6
Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of rectal lesions involving the dentate line.内镜黏膜下剥离术与内镜黏膜切除术治疗涉及齿状线的直肠病变。
Surg Endosc. 2024 Aug;38(8):4485-4495. doi: 10.1007/s00464-024-10994-6. Epub 2024 Jun 24.
7
[Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer].内镜-腹腔镜区域胃切除术联合前哨淋巴结清扫在早期胃癌患者中的应用研究
Zhonghua Wai Ke Za Zhi. 2025 Jul 1;63(7):587-596. doi: 10.3760/cma.j.cn112139-20250117-00034.
8
Endoscopic Submucosal Dissection of Large Gastric Hyperplastic Polyps: Clinicopathological Study From a Single Center.胃大增生性息肉的内镜下黏膜下剥离术:单中心临床病理研究
Cureus. 2025 Jul 28;17(7):e88911. doi: 10.7759/cureus.88911. eCollection 2025 Jul.
9
Risk Factors for Stricture After Endoscopic Submucosal Dissection of Large Rectal Neoplasms.大肠肿瘤内镜下黏膜下剥离术后狭窄的危险因素
Dis Colon Rectum. 2025 Sep 1;68(9):1112-1119. doi: 10.1097/DCR.0000000000003827. Epub 2025 Jun 13.
10
Application of artificial intelligence lesion labeling system-assisted endoscopic submucosal dissection for the treatment of esophageal lesions in a low-volume center: a prospective cohort study.人工智能病变标记系统辅助内镜黏膜下剥离术在低容量中心治疗食管病变中的应用:一项前瞻性队列研究
Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002748.

本文引用的文献

1
Comprehensive analysis of faecal metagenomic and serum metabolism revealed the role of gut microbes and related metabolites in detecting colorectal lateral spreading tumours.粪便宏基因组学和血清代谢组学的综合分析揭示了肠道微生物和相关代谢物在检测大肠侧向发育型肿瘤中的作用。
Virulence. 2025 Dec;16(1):2489154. doi: 10.1080/21505594.2025.2489154. Epub 2025 Apr 13.
2
Validation of a novel BCM model for recurrence risk prediction after mucosectomy of colorectal lateral spreading tumors in a European cohort.验证一种新型 BCM 模型在欧洲队列中结直肠侧向蔓延肿瘤黏膜切除术后复发风险预测中的应用。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102414. doi: 10.1016/j.clinre.2024.102414. Epub 2024 Jul 5.
3
Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2024.结直肠息肉切除术和内镜黏膜切除术:欧洲胃肠道内镜学会(ESGE)指南-2024 年更新。
Endoscopy. 2024 Jul;56(7):516-545. doi: 10.1055/a-2304-3219. Epub 2024 Apr 26.
4
NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score.NR5A2基因通过OCLR算法和免疫评分,经由SNP途径调节癌症干细胞活性,从而影响肺腺癌患者的总生存期。
Heliyon. 2024 Mar 28;10(7):e28282. doi: 10.1016/j.heliyon.2024.e28282. eCollection 2024 Apr 15.
5
Tumor-Infiltrating Lymphocytes and Adoptive Cell Therapy: State of the Art in Colorectal, Breast and Lung Cancer.肿瘤浸润淋巴细胞与过继细胞治疗:结直肠癌、乳腺癌和肺癌领域的最新进展
Physiol Res. 2023 Oct 27;72(S3):S209-S224. doi: 10.33549/physiolres.935155.
6
Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.结肠炎相关结直肠癌与散发性结直肠癌的差异免疫浸润谱
Cancers (Basel). 2023 Sep 27;15(19):4743. doi: 10.3390/cancers15194743.
7
Outcomes for Underwater Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection of 21-30-mm Colorectal Polyps: A Feasible Study.21 - 30毫米结直肠息肉的水下内镜黏膜切除术和内镜黏膜下剥离术的结果:一项可行性研究
Dig Dis Sci. 2023 Oct;68(10):3963-3973. doi: 10.1007/s10620-023-08093-y. Epub 2023 Sep 1.
8
Underwater endoscopic submucosal dissection for colorectal tumors: The next step in the "underwater evolution"?
J Gastroenterol Hepatol. 2023 Sep;38(9):1453-1454. doi: 10.1111/jgh.16339. Epub 2023 Aug 24.
9
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience.
Gastrointest Endosc. 2023 Sep;98(3):469. doi: 10.1016/j.gie.2023.03.005.
10
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer.低分子量肝素通过增加结直肠癌中的淋巴细胞浸润,与过继免疫和抗 PD-1 免疫疗法协同增强疗效。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007080.